Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Rosenblatt raised the price target for Fabrinet (NYSE:FN) from $260 to $280. Rosenblatt analyst Mike Genovese maintained a Buy rating. Fabrinet shares gained 0.2% to close at $231.55 on Monday. See how other analysts view this stock.
- Telsey Advisory Group cut the price target for The Estée Lauder Companies Inc. (NYSE:EL) from $115 to $105. Telsey Advisory Group analyst Dana Telsey maintained a Market Perform rating. Estée Lauder shares fell 2.2% to close at $92.85 on Monday. See how other analysts view this stock.
- B of A Securities cut Liquidia Corporation (NASDAQ:LQDA) price target from $24 to $23. B of A Securities analyst Greg Harrison maintained a Buy rating. Liquidia shares dipped 30.6% to close at $9.79 on Monday. See how other analysts view this stock.
- Keybanc boosted the price target for Palo Alto Networks, Inc. (NASDAQ:PANW) from $380 to $400. Keybanc analyst Eric Heath maintained an Overweight rating. Palo Alto shares gained 2.8% to close at $343.36 on Monday. See how other analysts view this stock.
- Baird slashed Snowflake Inc. (NYSE:SNOW) price target from $200 to $165. Baird analyst William Power maintained an Outperform rating. Snowflake shares gained 2.6% to close at $131.42 on Monday. See how other analysts view this stock.
- Jefferies raised ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) price target from $22 to $25. Jefferies analyst Omar Nokta maintained a Buy rating. ZIM Integrated Shipping shares gained 16.7% to close at $22.25 on Monday. See how other analysts view this stock.
- UBS increased the price target for Globant S.A. (NYSE:GLOB) from $225 to $235. UBS analyst Leonardo Olmos downgraded the stock from Buy to Neutral. Globant shares fell 1.1% to close at $201.98 on Monday. See how other analysts view this stock.
- Citigroup boosted Stride, Inc. (NYSE:LRN) price target from $77 to $90. Citigroup analyst Thomas Singlehurst downgraded the stock from Buy to Neutral. Stride shares gained 1.5% to close at $83.77 on Monday. See how other analysts view this stock.
- Bernstein boosted BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) price target from $94 to $110. Bernstein analyst William Pickering upgraded the stock from Market Perform to Outperform. BioMarin Pharmaceutical shares gained 3.6% to close at $92.76 on Monday. See how other analysts view this stock.
- Stifel raised Hyatt Hotels Corporation (NYSE:H) price target from $141 to $151. Stifel analyst Simon Yarmak maintained a Hold rating. Hyatt shares gained 2.5% to close at $146.67 on Monday. See how other analysts view this stock.
Considering buying Robinhood stock? Here's what analysts think:
- S&P 500, Nasdaq Extend Gains For 8th Consecutive Session: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone